Improving blood pressure control for patients in safety-net primary care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multi-site, hybrid effectiveness-implementation project uses a cluster randomized stepped-wedge design to roll out and compare two approaches: remote blood pressure monitoring (RBPM) alone and RBPM plus a multilevel intensification intervention (MII). The study will collect clinical outcomes and patient-reported outcomes while using mixed quantitative and qualitative methods guided by the RE-AIM framework to evaluate reach, adoption, fidelity, and maintenance. Each participating clinic will sequentially implement both approaches so sites can be compared within the pragmatic care setting. The design emphasizes real-world implementation in diverse, urban safety-net primary care populations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult (age\>18) patients receiving primary care at one of the 9 participating sites, with primary care provider (PCP) visit in the preceding year
* Presence of HTN defined by one or more of: 1) diagnosis included on active problem list, 2) active HTN medications in prior year, 3) 3 separate elevated BP measurements
* Uncontrolled HTN defined as systolic blood pressure (SBP)\>140

Exclusion Criteria:

* Not meeting the inclusion criteria

Where it's running

• Boston Healthcare for the Homeless (BHCHP)
  Boston, Massachusetts, United States Recruiting
• Boston Medical Center Family Medicine
  Boston, Massachusetts, United States Recruiting
• Boston Medical Center, General Internal Medicine primary care
  Boston, Massachusetts, United States Recruiting
• Neighborhood Health
  Boston, Massachusetts, United States Recruiting
• Mattapan Community Health Center
  Boston, Massachusetts, United States Recruiting
• Manet Community Health Center
  Quincy, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Michael Fischer, MD MS — Boston Medical Center, Internal Medicine
• Study coordinator: Michael Fischer, MD MS
• Email: Michael.Fischer@bmc.org
• Phone: (617) 414-7288

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using low-dose aspirin after preeclampsia to improve recovery

  This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.

  Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06281665

• IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension

  This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.

  Recruiting at 8 sites Bahir Dar University · Ādēt and 7 other locations · NCT07894068

• Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF

  This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.

  Recruiting London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario · NCT07893821

• Hypertension: Does Education Help Patients Manage Blood Pressure Better?

  This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.

  Recruiting Inonu University · Batman, Center · NCT07890090

• High BMI and periodontitis in Thai adults under 60

  This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.

  Recruiting Mahidol University · Bangkok, Ratchathewi · NCT07880717

• Long-term GW906 treatment for people with essential hypertension

  This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.

  Recruiting Shenzhen Salubris Pharmaceuticals Co., Ltd. · Shanghai, Shanghai Municipality · NCT07879755

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.